Document is current

Article History

Accepted: 9 October 2024

First Online: 23 October 2024

Declarations

:

: Dr. Greene has received research support from the Duke University Department of Medicine Chair’s Research Award, American Heart Association , Amgen, AstraZeneca, Boehinger Ingelheim, Bristol Myers Squibb, Cytokinetics, Merck, Novartis, Pfizer, and Sanofi; has served on advisory boards or as consultant for Amgen, AstraZeneca, Bayer, Boehringer Ingelheim, Bristol Myers Squibb, Corcept Therapeutics, Corteria Pharmaceuticals, CSL Vifor, Cytokinetics, Eli Lilly, Lexicon, Merck, Otsuka, Roche Diagnostics, Sanofi, scPharmaceuticals, Tricog Health, and Urovant Pharmaceuticals; and has received speaker fees from AstraZeneca, Bayer, Boehringer Ingelheim, Cytokinetics, Lexicon, and Roche Diagnostics. Dr. Sandhu has received research support from National Institutes of Health, American Heart Association , Novartis Pharmaceuticals, and Repreive Cardiovascular and has served as a consultant for Lexicon Pharmaceuticals. Dr. Go has received research support from the National Heart, Lung and Blood Institute and the National Institute of Diabetes, Digestive and Kidney Diseases. Dr. Ambrosy has received relevant research support through grants to his institution from the National Heart, Lung, and Blood Institute (K23HL150159), the American Heart Association (2nd Century Early Faculty Independence Award), The Permanente Medical Group, Northern California Community Benefits Programs, Garfield Memorial Fund, Abbott Laboratories, Amarin Pharma, Inc., Bayer, Cordio Medical, Edwards Lifesciences LLC, Esperion Therapeutics, Inc., Merck, and Novartis. Dr. Stephen J. Greene, Dr. Josephine Harrington, and Dr. Andrew P. Ambrosy are Editorial Board members of Heart Failure Reviews. All other authors report no relevant disclosures.